Cargando…
Alternative Management Options for Hypertrophic Cardiomyopathy: Feasible?
[Figure: see text]
Autores principales: | Raimondo, Cristina, Balsam, Pawel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8311710/ https://www.ncbi.nlm.nih.gov/pubmed/34317248 http://dx.doi.org/10.1016/j.jaccas.2020.02.002 |
Ejemplares similares
-
Cardiac Myxoma in a Patient With Hypertrophic Cardiomyopathy
por: Gi, Weng-Tein, et al.
Publicado: (2020) -
Novel FHL1 Mutation Associated With Hypertrophic Cardiomyopathy, Sudden Cardiac Death, and Myopathy
por: Binder, M. Scott, et al.
Publicado: (2020) -
The Ever-Expanding Landscape of Cardiomyopathies
por: Asatryan, Babken, et al.
Publicado: (2020) -
Genetic Counseling in Inherited Cardiomyopathies
por: Moharem-Elgamal, Sarah, et al.
Publicado: (2020) -
Defying the Odds of Sudden Cardiac Death in Hypertrophic Cardiomyopathy
por: Rostomian, Ara H., et al.
Publicado: (2020)